AMMJ · As filed with the SEC
American Cannabis Company income statement, by fiscal year
The statement as American Cannabis Company presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS · USD, except per-share amounts
| USD, except per-share amounts | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 |
|---|---|---|---|---|
| Revenues | ||||
| Consulting Services | — | — | 381,094 | 505,363 |
| Product & Equipment | — | — | 1,037,962 | 1,064,431 |
| Cannabis Products | — | — | 1,006,148 | — |
| Consulting Services | 695,089 | 475,837 | — | — |
| Product & Equipment | 1,024,191 | 17,539,377 | — | — |
| Cannabis Products | 756,905 | 793,331 | — | — |
| Total Revenues | 2,476,185 | 18,808,545 | 2,425,204 | 1,569,794 |
| Cost of Revenue | ||||
| Cost of Consulting Services | — | — | 36,179 | 108,706 |
| Cost of Products and Equipment | — | — | 758,940 | 740,409 |
| Cost of Cannabis Products | — | — | 573,937 | — |
| Cost of Consulting Services | 115,085 | 61,246 | — | — |
| Cost of Products and Equipment | 724,921 | 15,230,648 | — | — |
| Cost of Cannabis Products | 594,296 | 979,437 | — | — |
| Total Cost of Revenues | 1,434,302 | 16,271,331 | 1,369,056 | 849,115 |
| Gross Profit | 10,141,882 | 2,537,214 | 1,056,148 | 720,679 |
| Operating Expenses | ||||
| Selling, General and Administrative Expense | 1,650,498 | 2,833,140 | 2,050,272 | 1,010,902 |
| Selling, General and Administrative Expense | 154,470 | 225,950 | 199,968 | 298,937 |
| Bad Debt Expense | — | — | 54,435 | 4,910 |
| Litigation Settlement Expense | — | — | 350,000 | — |
| Stock Based Compensation Expense | — | — | 42,206 | 29,970 |
| Bad Debt Expense | 20,933 | 5,438 | — | — |
| Goodwill Impairment | 1,332,113 | — | — | — |
| Stock Based Compensation Expense | 1,735,021 | 78,342 | — | — |
| Total Operating Expenses | 4,893,035 | 3,142,870 | 2,696,881 | 1,344,719 |
| Loss from Operations | (3,851,152) | (605,656) | (1,640,733) | (624,040) |
| Interest (expense) | — | — | — | (1,786) |
| Other Income (Expense) | ||||
| Interest (expense) | (113,609) | (78,086) | (75,374) | — |
| Debt Forgiveness | — | — | 240,975 | — |
| Other Income | 304,345 | 50,550 | 35,883 | 93,413 |
| Total Other Income | — | — | — | 91,627 |
| Net Income | — | — | — | (532,413) |
| Total Other (Expense) Income | 190,736 | (27,536) | 201,484 | — |
| Net Loss | — | — | (1,439,249) | — |
| Net Loss | (3,660,416) | (633,192) | — | — |
| Basic net loss per common share | — | — | — | (0.01) |
| Weighted Average Shares Outstanding, Diluted | — | — | — | 57,548,474 |
| NET LOSS | — | — | (1,439,249) | — |
| Basic and diluted net loss per common share | — | — | (0.02) | — |
| Basic and diluted weighted average common shares outstanding | — | — | 78,387,733 | — |
| NET LOSS | — | (633,192) | — | — |
| NET LOSS | (3,660,416) | — | — | — |
| Basic and diluted net loss per common share | (0.03) | (0.01) | — | — |
| Basic and diluted weighted average common shares outstanding | 109,911,842 | 85,727,938 | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.